Prothena Corp (PRTA) 49.98 $PRTA Prothena to Participate

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Prothena Corp (PRTA) 49.98 $PRTA

Prothena to Participate in Upcoming September Investor Conferences
Globe Newswire - Tue Aug 30, 3:05PM CDT
DUBLIN, Ireland, Aug. 30, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQRTA), a late-stage clinical biotechnology company focused on the discovery, development, and commercialization of novel protein immunotherapies, today announced that members of its senior management team will present and participate in several upcoming investor conferences:
PRTA: 49.98 (-0.54)

Prothena (PRTA) Reports Wider-than-Anticipated Loss in Q2
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 9:45AM CDT
Prothena (PRTA) reported a wider-than-expected loss of $1.18 per share in the second quarter of 2016.
ZTS: 51.10 (+0.35), ANIP: 59.74 (-1.12), PRTA: 49.98 (-0.54)

Prothena Reports Second Quarter 2016 Financial Results; Provides R&D Update
Globe Newswire - Tue Aug 02, 3:05PM CDT
- Net cash used in operating and investing activities was $32.3 million in the second quarter and $57.7 million for the first six months of 2016; strong quarter-end cash and restricted cash position of $447.0 million supports advancement of multiple clinical development programs
PRTA: 49.98 (-0.54)

What Awaits MNK & Other Drug Stocks this Earnings Season?
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 9:00AM CDT
Let's see what's in store for some medical companies that are expected to declare quarterly numbers on Aug 2.
MNK: 74.54 (-0.51), BIIB: 305.63 (-2.23), ABT: 42.02 (-0.81), JNJ: 119.34 (-0.13), GILD: 78.38 (+0.46), MRK: 62.79 (+0.08), PFE: 34.80 (-0.08), SGNT: 21.76 (+0.03), ABBV: 64.10 (-0.06), PRTA: 49.98 (-0.54), NVS: 78.77 (-0.57)

What's in Store for Prothena (PRTA) This Earnings Season?
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 3:44PM CDT
Prothena Corporation plc (PRTA) is expected to report second-quarter 2016 results on Aug 2.
IPXL: 24.19 (-0.23), IRWD: 13.34 (-0.08), PRTA: 49.98 (-0.54), EXEL: 11.15 (+0.11)

Prothena Reports Results of Phase 1 Single Ascending Dose Study of PRX003, Demonstrating Target Engagement of the Novel Anti-MCAM Antibody for Inflammatory Diseases
Globe Newswire - Thu Jun 09, 3:05PM CDT
- All doses of PRX003 found to be safe and well tolerated, meeting the primary objective of the Phase 1 single ascending dose study in healthy volunteers
PRTA: 49.98 (-0.54)

Prothena to Present Wide Range of Studies on Amyloidosis, Including New Clinical Data on NEOD001, at International Symposium on Amyloidosis
Globe Newswire - Mon May 23, 3:05PM CDT
- New clinical data to be presented from expansion cohort of Phase 1/2 trial of NEOD001 for the potential treatment of AL amyloidosis
PRTA: 49.98 (-0.54)

Prothena to Present Quality of Life Data on AL Amyloidosis at European Hematology Association 21st Congress
Globe Newswire - Thu May 19, 3:05PM CDT
DUBLIN, Ireland, May 19, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NasdaqRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapies, today announced that data from multiple quality of life studies in patients with AL amyloidosis will be highlighted at The European Hematology Association (EHA) 21st Congress to be held June 9-12 in Copenhagen, Denmark.
PRTA: 49.98 (-0.54)

Prothena to Present Clinical Results From its Phase 1 Single Ascending Dose Study of PRX003, an Anti-MCAM Antibody Being Investigated for Inflammatory Diseases, at EULAR 2016
Globe Newswire - Mon May 09, 3:05PM CDT
DUBLIN, Ireland, May 09, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NasdaqRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapies, today announced that clinical data from its Phase 1 single ascending dose study of PRX003 in healthy volunteers will be highlighted in an oral presentation at The European League Against Rheumatism Annual European Congress of Rheumatology (EULAR 2016) to be held June 8-11 in London.
PRTA: 49.98 (-0.54)

Prothena (PRTA) Reports Wider-than-Expected Loss in Q1
Zacks Equity Research - Zacks Investment Research - Wed May 04, 12:00PM CDT
Prothena Corporation plc (PRTA) reported a loss of 81 cents per share in the first quarter of 2016, much wider than both the Zacks Consensus Estimate of a loss of 70 cents.
SHPG: 187.18 (-3.04), PRTA: 49.98 (-0.54), NKTR: 17.85 (+0.34)

Prothena Reports First Quarter 2016 Financial Results and Provides R&D Update
Globe Newswire - Tue May 03, 3:05PM CDT
- Net cash used in operating and investing activities was $25.4 million in the first quarter; strong quarter-end cash position of $474.3 million, including net proceeds of $128.6 million raised through January 2016 public equity offering, supports advancement of multiple clinical development programs
PRTA: 49.98 (-0.54)

Drug Stocks Q1 Earnings Preview: AEGR, AERI, MACK, PRTA
Zacks Equity Research - Zacks Investment Research - Fri Apr 29, 8:04AM CDT
The going has been quite satisfactory as we stand in the thick of the first earnings season of the year.
MACK: 4.62 (-0.06), BIIB: 305.63 (-2.23), ABT: 42.02 (-0.81), JNJ: 119.34 (-0.13), AERI: 19.36 (-0.06), AEGR: 1.63 (+0.01), PRTA: 49.98 (-0.54)

Prothena (PRTA): What's Ahead for the Stock in Q1 Earnings?
Zacks Equity Research - Zacks Investment Research - Wed Apr 27, 5:42PM CDT
Prothena (PRTA) is expected to report first-quarter 2016 earnings on May 3.
ZTS: 51.10 (+0.35), AGIO: 36.84 (+0.22), PRTA: 49.98 (-0.54)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

King Technology Bets Big on Missouri, $17M Investment

Updated Category News Views 0

A Dive into King Technology's Strategic Move King Technology is making waves like a cannonball in the kiddie pool with its new $17 million manufacturing and distribution center in St. Peters, Missouri. This isn't just pocket change being thrown around here—it's a calculated step in their game plan to boost efficiency and lock in some serious distribution prowess across...

Continue Reading
Skiptown Expands into Austin: A New Pet Care Frontier

Updated Category News Views 0

Skiptown Marches into the Heart of Texas A move into Texas? Now that's got potential written all over it. Skiptown's making waves by dropping anchor in Austin with a five-unit franchise agreement. We're talking modern dog daycare and more, right in the heart of Central Texas. First up, fall 2027 is when you can circle the calendar. Expect to see more locations sprout up...

Continue Reading
Bryan Park's Vision Drives Footprints' Surging Growth

Updated Category News Views 0

An Airman’s Mission of Building Legacies When you think of flooring, 'admired CEOs' probably don’t top the list. Yet here’s Bryan Park, an ex-Air Force veteran, shaking things up and earning a nod from the Denver Business Journal. Named one of the Most Admired CEOs of 2026, Park has taken what began as a small flooring operation and turned it into a national...

Continue Reading
Teamsters Triumph: Court Backs Workers' Health Benefits

Updated Category News Views 0

Court Orders Health Coverage Amid Creamery Dispute Good grief! Just when you think you've seen all the punches the corporate world can throw, something like this comes along. The court's declaration that Dairy Farmers of America (DFA) must keep providing health care to members of Teamsters Local 597 is pushing back the tides for workers at the St. Albans Creamery. This...

Continue Reading
Virginia's 3D Printing Push: Affordable Housing Revolution

Updated Category News Views 0

Pioneering Affordable Homes with 3D Printing There’s something brewing in Henrico County that’s got the potential to shake up the entire construction industry: 3D printing. Now, hold your horses if you think this isn’t about stock tickers flashing green or red. Sometimes it’s just about reimagining what living affordable means. With Richmond Metropolitan Habitat...

Continue Reading
Sarwant Singh Propels Frost & Sullivan's AI Ambitions

Updated Category News Views 0

A Veteran Strategist Returns to the Fold Sharp moves in the corporate world don't always grab headlines, but sometimes you’ve got to stop and consider the buzzworthy comebacks. Keep your eyes peeled for Sarwant Singh's return to Frost & Sullivan, a noteworthy shift that’s shaping the landscape of digital strategies and beyond. Turning Up the Heat on Digital Innovation...

Continue Reading
Survey Says 92% Report Better Life Post-Rehab

Updated Category News Views 0

92% Say Life Improves After TranquilHearts' Treatment It's not every day you see 92% of folks claiming something actually worked for them, huh? That's exactly the kind of figure TranquilHearts Rehab's alumni claimed in their recent survey about improved quality of life post-treatment. But let's not get ahead of ourselves with high-fives and celebration just yet. Here's...

Continue Reading
National Solar Tour 2026: Discover Solar Power Live

Updated Category News Views 0

Experience Real-Life Solar Innovations It's always worth raising an eyebrow when a grassroots event, that's been kicking around for over three decades, rolls around just waving at us to take part. The National Solar Tour 2026 is crash-landing this weekend, October 2-4, like clockwork, bringing solar tech right to your front porch, figuratively and literally speaking. Get...

Continue Reading
Oak Farms Invests in Texas Schools and Students

Updated Category News Views 0

Putting Money Where Their Roots Are You have to hand it to Oak Farms; when they say they're rooted in Texas, they actually back it up with some cold, hard cash. They've lined up $27,500 for schools and students across the state. That's the kind of talking I like to see—straight from the brand to the community ledger. No fluff, just good old-fashioned giving in the form...

Continue Reading
New Class L Sparks NYC's Lithium-ion Fire Concerns

Updated Category News Views 0

Lithium-Ion Fires: A Burning Reality in NYC Hold onto your hats, because if you're caught up in NYC's energy scene, you're about to navigate some fiery waters. The International Organization for Standardization (ISO) has tossed us a new curveball by cooking up Class L for lithium-ion battery fires. This isn't just alphabet soup—they're addressing the unique explosive...

Continue Reading

Top 5 Most Recently Viewed Articles

Three Wealth-Building Stocks to Consider Today

Updated Category News Views 135

Investing for Growth: A Balanced Approach Investing offers a rewarding journey with multiple paths to financial success. Whether you prefer high-growth stocks or reliable dividend payers, wealth can be built through various strategies. The key, however, lies in choosing stocks that represent high-quality businesses. A quality company is defined by its consistent growth...

Continue Reading
Bio-Path Initiates Obesity Program with BP1001-A Candidate

Updated Category News Views 50

Bio-Path's New Venture into Obesity Treatment Bio-Path Holdings, Inc. has taken a significant leap forward by initiating a new therapeutic program focused on obesity and related metabolic diseases. This groundbreaking program revolves around the development of BP1001-A, leveraging their proprietary DNAbilize technology. This marks an exciting shift in direction, as it is...

Continue Reading
Exciting Developments in AI for Breast Cancer Surgery Technology

Updated Category News Views 109

Innovative Trial Results from the B-Series OCT with ImgAssist AI Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) has made significant strides in breast cancer surgery technology with the release of impactful results from its pivotal trial focusing on their B-Series OCT with ImgAssist AI 2.0. This pioneering intraoperative margin assessment technology is...

Continue Reading
Honoring Prof. Ranjan Singh as APL Engineering Physics Editor

Updated Category News Views 151

Prof. Ranjan Singh Takes the Helm as Editor-in-Chief AIP Publishing is thrilled to announce the appointment of Prof. Ranjan Singh, a distinguished figure in the field of photonics and metamaterials, as the founding editor-in-chief of APL Engineering Physics. His groundbreaking research and leadership experience promise to elevate the journal's mission of fostering...

Continue Reading
Key Details on Shares and Voting Rights for Fnac Darty

Updated Category News Views 132

Overview of Fnac Darty's Shares and Voting Rights Understanding the total number of shares and voting rights is essential for stakeholders in Fnac Darty. The company is listed on the Euronext Paris stock exchange and follows compliance with the French commercial code and financial regulations. This transparency ensures that current and potential investors have access to...

Continue Reading